Alternative splicing and caspase-mediated cleavage generate antagonistic variants of the stress oncoprotein LEDGF/p75.

Molecular Cancer Research : MCR
Terry A Brown-BryanCarlos A Casiano

Abstract

There is increasing evidence that an augmented state of cellular oxidative stress modulates the expression of stress genes implicated in diseases associated with health disparities such as certain cancers and diabetes. Lens epithelium-derived growth factor p75 (LEDGF/p75), also known as DFS70 autoantigen, is emerging as a survival oncoprotein that promotes resistance to oxidative stress-induced cell death and chemotherapy. We previously showed that LEDGF/p75 is targeted by autoantibodies in prostate cancer patients and is overexpressed in prostate tumors, and that its stress survival activity is abrogated during apoptosis. LEDGF/p75 has a COOH-terminally truncated splice variant, p52, whose role in stress survival and apoptosis has not been thoroughly investigated. We observed unbalanced expression of these proteins in a panel of tumor cell lines, with LEDGF/p75 generally expressed at higher levels. During apoptosis, caspase-3 cleaved p52 to generate a p38 fragment that lacked the NH(2)-terminal PWWP domain and failed to transactivate the Hsp27 promoter in reporter assays. However, p38 retained chromatin association properties and repressed the transactivation potential of LEDGF/p75. Overexpression of p52 or its variants with t...Continue Reading

References

Jun 16, 2000·The Journal of Allergy and Clinical Immunology·R L OchsE M Tan
Oct 12, 2000·Biochemical and Biophysical Research Communications·P SharmaT Shinohara
May 15, 2001·Biochemical and Biophysical Research Communications·D P SinghT Shinohara
Jun 8, 2002·Progress in Retinal and Eye Research·Toshimichi ShinoharaNigar Fatma
Dec 24, 2002·Progress in Molecular and Subcellular Biology·J Y WuN Havlioglu
Mar 26, 2003·Cell Death and Differentiation·U FischerK Schulze-Osthoff
May 27, 2003·BioTechniques·Rosa A CarrascoBharvin K R Patel
Sep 11, 2003·Autoimmunity Reviews·Vidya GanapathyCarlos A Casiano
Mar 5, 2004·The Journal of Biological Chemistry·Ying-Zi GeGuo-Liang Xu
Mar 17, 2004·Arthritis and Rheumatism·Vidya Ganapathy, Carlos A Casiano
May 4, 2004·Methods : a Companion to Methods in Enzymology·Linda B JacobsenMaryJo Wright
Nov 4, 2004·Integrative Cancer Therapies·Carmia Borek
Dec 25, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S K PathakA J Gescher
Feb 4, 2005·Protein Science : a Publication of the Protein Society·Nobukazu NamekiShigeyuki Yokoyama
Feb 24, 2005·Leukemia Research·Cristina MorerioClaudio Panarello
Jun 29, 2005·Leukemia Research·Francis H GrandSteven L Allen
Jul 2, 2005·Molecular Cell·Christian Schwerk, Klaus Schulze-Osthoff
Oct 19, 2005·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·J Daniel PenningtonDavid Gius
Dec 31, 2005·Protein Science : a Publication of the Protein Society·Stephen M LukasikJohn H Bushweller
Jan 13, 2006·Trends in Biochemical Sciences·Bénédicte Van MaeleZeger Debyser
Jan 13, 2006·American Journal of Physiology. Cell Physiology·Yoshihiro TakamuraDhirendra P Singh
Mar 21, 2006·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Julian P Venables
May 23, 2006·Journal of Autoimmunity·Yoshinao MuroYasushi Tomita
May 30, 2006·Trends in Genetics : TIG·Angela Ciuffi, Frederic D Bushman
Jun 22, 2006·Journal of Cell Science·Anabella Srebrow, Alberto R Kornblihtt

❮ Previous
Next ❯

Citations

May 21, 2010·Nucleic Acids Research·Jan De RijckRik Gijsbers
Sep 15, 2011·PloS One·Regina BökenkampAdriana C Gittenberger-de Groot
Oct 1, 2009·Future Medicinal Chemistry·Arnout Rd VoetFrauke Christ
Oct 25, 2011·Journal of Molecular Biology·Sébastien DesfargesAngela Ciuffi
Jan 1, 2012·Cancers·Erica Ballabio, Thomas A Milne
Apr 13, 2018·Clinical and Experimental Immunology·R NisiharaT L Skare
Jul 10, 2012·Nature Structural & Molecular Biology·Mads DaugaardMarja Jäättelä
Sep 11, 2016·Journal of Hematology & Oncology·Rosalia de Necochea-CampionChien-Shing Chen
Nov 30, 2016·Auto- Immunity Highlights·Mónica Vázquez-Del MercadoCarlos A Casiano
May 18, 2019·Cellular and Molecular Life Sciences : CMLS·Nicholas T Crump, Thomas A Milne
Mar 21, 2017·Auto- Immunity Highlights·Kishore Malyavantham, Lakshmanan Suresh
Jun 3, 2021·International Journal of Molecular Sciences·Victoria LiedtkeLysann Schenk

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis